X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (333) 333
Book / eBook (49) 49
Publication (40) 40
Book Review (11) 11
Patent (4) 4
Conference Proceeding (2) 2
Paper (2) 2
Art (1) 1
Book Chapter (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
Streaming Audio (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (163) 163
index medicus (102) 102
female (97) 97
male (90) 90
adult (68) 68
middle aged (67) 67
infectious diseases (44) 44
aged (43) 43
pharmacology & pharmacy (34) 34
immunology (33) 33
hiv infections - drug therapy (27) 27
clinical neurology (25) 25
analysis (22) 22
hiv (22) 22
virology (21) 21
microbiology (20) 20
health aspects (19) 19
pharmacokinetics (19) 19
risk factors (19) 19
adolescent (17) 17
care and treatment (17) 17
child (17) 17
history (17) 17
hiv-1 (16) 16
aids (14) 14
drug interactions (14) 14
animals (13) 13
antiretroviral therapy (13) 13
drug therapy, combination (13) 13
epilepsy - blood (13) 13
hematology (13) 13
medicine (13) 13
medicine & public health (13) 13
parkinson disease - drug therapy (13) 13
prospective studies (13) 13
research (13) 13
disease (12) 12
dose-response relationship, drug (12) 12
italy (12) 12
toxicology (12) 12
biochemistry & molecular biology (11) 11
disease progression (11) 11
drug monitoring (11) 11
drug therapy (11) 11
epilepsy - drug therapy (11) 11
hiv infection (11) 11
hiv infections - immunology (11) 11
infection (11) 11
levodopa (11) 11
multidisciplinary sciences (11) 11
patients (11) 11
therapy (11) 11
anticonvulsants - blood (10) 10
carbamazepine (10) 10
epidemiology (10) 10
hiv infections - complications (10) 10
human immunodeficiency virus--hiv (10) 10
metabolism (10) 10
neurosciences (10) 10
time factors (10) 10
association (9) 9
cells (9) 9
epilepsy (9) 9
follow-up studies (9) 9
levodopa - pharmacokinetics (9) 9
research article (9) 9
retrospective studies (9) 9
settore med/17 - malattie infettive (9) 9
virus diseases (9) 9
activation (8) 8
anticonvulsants - therapeutic use (8) 8
antiepileptic drugs (8) 8
antiretroviral drugs (8) 8
expression (8) 8
flow cytometry (8) 8
hiv infections - virology (8) 8
lymphocytes t (8) 8
management (8) 8
prognosis (8) 8
protease inhibitors (8) 8
risk (8) 8
treatment outcome (8) 8
young adult (8) 8
anti-hiv agents - administration & dosage (7) 7
anti-hiv agents - adverse effects (7) 7
anticonvulsants (7) 7
carbamazepine - analogs & derivatives (7) 7
carbamazepine - blood (7) 7
child, preschool (7) 7
cohort studies (7) 7
complications and side effects (7) 7
diagnosis (7) 7
drug administration schedule (7) 7
genotype (7) 7
infections (7) 7
italy - epidemiology (7) 7
levodopa - blood (7) 7
levodopa - therapeutic use (7) 7
lymphocytes (7) 7
mortality (7) 7
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (22) 22
UTL at Downsview - May be requested (19) 19
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Pontifical Inst. Mediaeval Studies - Library use only (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Stacks (1) 1
Music - Stacks (1) 1
Online Resources - Online (1) 1
Pontifical Inst. Mediaeval Studies - On order (1) 1
Robarts - Course Reserves (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (332) 332
Italian (77) 77
French (10) 10
German (7) 7
Spanish (5) 5
Latin (2) 2
Ancient Greek (1) 1
Greek (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Gastroenterology, ISSN 0002-9270, 06/2012, Volume 107, Issue 6, pp. 922 - 931
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, pp. e0123670 - e0123670
Introduction Ritonavir-boosted atazanavir (ATV/r) is a relatively well tolerated antiretroviral drug. However, side effects including hyperbilirubinemia,... 
UNBOOSTED ATAZANAVIR | BILIRUBIN | HYPERBILIRUBINEMIA | EFFICACY | PHARMACOKINETICS | TOLERABILITY | MULTIDISCIPLINARY SCIENCES | ANTIRETROVIRAL THERAPY | RENAL STONES | POLYMORPHISM | RITONAVIR-BOOSTED ATAZANAVIR | Nephrolithiasis - chemically induced | Atazanavir Sulfate - administration & dosage | Humans | Middle Aged | Male | Atazanavir Sulfate - adverse effects | Atazanavir Sulfate - pharmacokinetics | Drug Dosage Calculations | Dyslipidemias - blood | HIV-1 - physiology | Ritonavir - adverse effects | HIV Protease Inhibitors - pharmacokinetics | Hyperbilirubinemia - chemically induced | Adult | Female | Hyperbilirubinemia - physiopathology | Nephrolithiasis - physiopathology | Dyslipidemias - diagnosis | HIV Protease Inhibitors - adverse effects | HIV Protease Inhibitors - blood | Atazanavir Sulfate - blood | Drug Administration Schedule | Hyperbilirubinemia - diagnosis | HIV-1 - drug effects | HIV Infections - virology | Nephrolithiasis - blood | HIV Protease Inhibitors - administration & dosage | Nephrolithiasis - diagnosis | Antiretroviral Therapy, Highly Active | Hyperbilirubinemia - blood | Dyslipidemias - chemically induced | HIV Infections - drug therapy | Drug Monitoring | Viral Load - drug effects | Dyslipidemias - physiopathology | Highly active antiretroviral therapy | HIV patients | HIV (Viruses) | Health aspects | HIV infection | Analysis | Antiretroviral drugs | Toxicity | Ritonavir | Complications | Dyslipidemia | Lipids | Nephrolithiasis | Dosage | Patients | Side effects | Hyperbilirubinemia | Acquired immune deficiency syndrome--AIDS | Protease inhibitors | Antiretroviral agents | Human immunodeficiency virus--HIV | All terrain vehicles | Index Medicus | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2013, Volume 110, Issue 29, pp. 11970 - 11975
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 06/2017, Volume 73, Issue 6, pp. 789 - 790
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00228-017-2231-5 
PHARMACOLOGY & PHARMACY | DRUGS | Antiviral agents
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2013, Volume 8, Issue 12, p. e80242
Treatment with tenofovir sometimes leads to non-reversible kidney and/or bone diseases. Factors associated with these drug-related adverse events are poorly... 
KIDNEY-DISEASE | THERAPY | POPULATION PHARMACOKINETICS | MULTIDISCIPLINARY SCIENCES | EFAVIRENZ | EMTRICITABINE | POSITIVE PATIENTS | COHORT | ASSOCIATION | HIV-INFECTED PATIENTS | IMPAIRMENT | Bone Resorption - physiopathology | Adenine - analogs & derivatives | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Risk Factors | Organophosphonates - adverse effects | Body Weight - drug effects | Adenine - pharmacokinetics | Adenine - administration & dosage | Organophosphonates - pharmacokinetics | Anti-HIV Agents - administration & dosage | Tenofovir | Organophosphonates - administration & dosage | Adenine - adverse effects | Anti-HIV Agents - pharmacokinetics | Bone Resorption - metabolism | Adult | Female | HIV Infections - drug therapy | Bone Resorption - chemically induced | HIV Infections - physiopathology | HIV Infections - metabolism | Body weight | Dosage and administration | Research | Bone diseases | Females | Drug therapy | Health aspects | Creatinine | Demineralizing | Antiretroviral drugs | Renal function | Demineralization | Toxicity | Complications | Gender differences | Regression analysis | Patients | Risk factors | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Bone demineralization | Bone | Proteinuria | Kidney transplantation | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Journal Article
Journal Article
Annals of Pharmacotherapy, ISSN 1060-0280, 10/2019, p. 106002801988381
Journal Article
Journal Article
Seminars in Immunology, ISSN 1044-5323, 2012, Volume 24, Issue 3, pp. 225 - 230
Journal Article
Journal of Virology, ISSN 0022-538X, 10/2018, Volume 92, Issue 20
A recent study conducted in blood has proposed CD32 as the marker identifying the "elusive" HIV reservoir. We have investigated the distribution of CD32(+) CD4... 
Human immunodeficiency virus | Lymph node | Tfh cells | PD-1 | CD32 | AIDS | PROLIFERATION | REPLICATION-COMPETENT | HUMAN-IMMUNODEFICIENCY-VIRUS | CXC CHEMOKINE RECEPTOR-5 | TISSUE RESERVOIRS | VIROLOGY | lymph node | ACTIVE ANTIRETROVIRAL THERAPY | human immunodeficiency virus | STEM-CELL | INFECTION | LATENT RESERVOIR
Journal Article